Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

17 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Exenatide once weekly decreases urinary albumin excretion in patients with type 2 diabetes and elevated albuminuria: Pooled analysis of randomized active controlled clinical trials.
van der Aart-van der Beek AB, van Raalte DH, Guja C, Hoogenberg K, Suchower LJ, Hardy E, Sjöström CD, Heerspink HJL. van der Aart-van der Beek AB, et al. Among authors: suchower lj. Diabetes Obes Metab. 2020 Sep;22(9):1556-1566. doi: 10.1111/dom.14067. Epub 2020 May 29. Diabetes Obes Metab. 2020. PMID: 32329160 Free PMC article. Clinical Trial.
Long-term effects of dapagliflozin plus saxagliptin versus glimepiride on a background of metformin in patients with type 2 diabetes: Results of a 104-week extension to a 52-week randomized, phase 3 study and liver fat MRI substudy.
Frías JP, Maaske J, Suchower L, Johansson L, Hockings PD, Iqbal N, Wilding JPH. Frías JP, et al. Among authors: suchower l. Diabetes Obes Metab. 2022 Jan;24(1):61-71. doi: 10.1111/dom.14548. Epub 2021 Sep 28. Diabetes Obes Metab. 2022. PMID: 34514692 Free PMC article. Clinical Trial.
Long-term treatment with the dipeptidyl peptidase-4 inhibitor saxagliptin in patients with type 2 diabetes mellitus and renal impairment: a randomised controlled 52-week efficacy and safety study.
Nowicki M, Rychlik I, Haller H, Warren M, Suchower L, Gause-Nilsson I, Schützer KM. Nowicki M, et al. Among authors: suchower l. Int J Clin Pract. 2011 Dec;65(12):1230-9. doi: 10.1111/j.1742-1241.2011.02812.x. Epub 2011 Oct 7. Int J Clin Pract. 2011. PMID: 21977965 Clinical Trial.
Accuracy of CLOtest after Helicobacter pylori therapy.
Laine L, Suchower L, Johnson E, Ronca P, Neil G. Laine L, et al. Among authors: suchower l. Gastrointest Endosc. 1998 Mar;47(3):250-3. doi: 10.1016/s0016-5107(98)70321-9. Gastrointest Endosc. 1998. PMID: 9540877 Clinical Trial.
17 results